Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Linagliptin”

Showing 20 of 0 results

Not applicableStudy completedNCT04735042
What this trial is testing

SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of the Genito-urinary Tract and Risk of Infections.

Who this might be right for
Type 2 DiabetesUrinary Tract Infections
University of Pisa 60
Large-scale testing (Phase 3)Study completedNCT01778049
What this trial is testing

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 708
Large-scale testing (Phase 3)Study completedNCT02897349
What this trial is testing

Linagliptin Add-on to Insulin Background Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 206
Early research (Phase 1)Study completedNCT02183363
What this trial is testing

Bioavailability of BI 1356 After Single Oral Administration Given as Different Tablet Formulation in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 24
Early research (Phase 1)Study completedNCT02183623
What this trial is testing

The Effect of Multiple Oral Doses of BI 1356 BS on Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of Simvastatin and on the Pharmacokinetics of Its Metabolite Simvastatin Acid in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 20
Early research (Phase 1)Study completedNCT02821910
What this trial is testing

Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Linagliptin/Metformin Extended Release Compared With Single Tablets

Who this might be right for
Healthy
Boehringer Ingelheim 50
Early research (Phase 1)Study completedNCT07039890
What this trial is testing

To Compare and Evaluate the Oral Bioavailability of Empagliflozin + Linagliptin 10 mg/5 mg Filmcoated Tablets With That of Glyxambi 10 mg/ 5 mg Film-coated Tablets in Healthy, Adult, Human Subjects Under Fasting Conditions.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Humanis Saglık Anonim Sirketi 40
Early research (Phase 1)Study completedNCT02183415
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS as Tablet in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 77
Early research (Phase 1)Study completedNCT03250052
What this trial is testing

A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 39
Testing effectiveness (Phase 2)Study completedNCT02183324
What this trial is testing

BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 72
Early research (Phase 1)Study completedNCT02183376
What this trial is testing

Pharmacokinetics and Pharmacodynamics of BI 1356 in Subjects With Different Degrees of Liver Impairment as Compared to Healthy Subjects

Who this might be right for
Hepatic Insufficiency
Boehringer Ingelheim 33
Post-approval studies (Phase 4)Study completedNCT03004612
What this trial is testing

Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes

Who this might be right for
Prediabetic StateInsulin Resistance
Universidad de Guanajuato 144
Early research (Phase 1)Study completedNCT01189201
What this trial is testing

Rel. BA of Empagliflozin (BI 10773)/Linagliptin FDC Tbl, Comparison With Mono-components, With a Second FDC Tablet and Influence of Food

Who this might be right for
Healthy
Boehringer Ingelheim 42
Early research (Phase 1)Study completedNCT02815644
What this trial is testing

Empa/Lina FDC Food Effect Study (Japan)

Who this might be right for
Healthy
Boehringer Ingelheim 22
Early research (Phase 1)Study completedNCT02758171
What this trial is testing

Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Linagliptin Compared With the Free Combination of Empagliflozin Tablet and Linagliptin Tablet in Healthy Male and Female Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 56
Post-approval studies (Phase 4)Study completedNCT01897532
What this trial is testing

Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 6,991
Large-scale testing (Phase 3)UnknownNCT04131582
What this trial is testing

Effect of Empagliflozin + Linagliptin + Metformin + Lifestyle in Patients With Prediabetes

Who this might be right for
Prediabetic StateInsulin Resistance
Universidad de Guanajuato 34
Post-approval studies (Phase 4)UnknownNCT02097342
What this trial is testing

Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusInsulin Sensitivity/Resistance
Post Graduate Institute of Medical Education and Research, Chandigarh 30
Early research (Phase 1)Study completedNCT02183532
What this trial is testing

Pharmacokinetics of Single and Multiple Oral Doses of BI 1356 in Healthy Chinese Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 12
Testing effectiveness (Phase 2)Study completedNCT03667300
What this trial is testing

Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency

Who this might be right for
Type2 Diabetes MellitusAlbuminuriaRenal Insufficiency
Samsung Medical Center 209
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation